Wordt geladen...
Limiting the priming dose of a SARS CoV-2 vaccine improves virus-specific immunity
Since late 2019, SARS-CoV-2 has caused a global pandemic that has infected 128 million people worldwide. Although several vaccine candidates have received emergency use authorization (EUA), there are still a limited number of vaccine doses available. To increase the number of vaccinated individuals,...
Bewaard in:
| Gepubliceerd in: | bioRxiv |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Cold Spring Harbor Laboratory
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8020975/ https://ncbi.nlm.nih.gov/pubmed/33821275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.03.31.437931 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|